Supreme Court ruling on abortion drug could weaken the FDA’s authority
The U.S. Supreme Court has begun deliberations over the case that will determine accessibility to the most commonly used abortion medication in the country, mifepristone. The Food and Drug Administration v. Alliance for Hippocratic Medicine began oral arguments on Tuesday, March 26, and a decision is expected by the summer, according to The Washington Post.
In 2023, mifepristone became the most commonly used abortion treatment in the United States, accounting for over 60% of abortion treatments, the Post reported. It has become a more accessible abortion treatment, particularly for Americans living in rural areas where there are few clinics and for those living in states with strict abortion laws.
Mount Holyoke professors discuss why 2024 is the ‘biggest year in election history’
On Wednesday, Feb. 28, Mount Holyoke students and community members gathered in Hooker Auditorium to attend a McCulloch Center for Global Initiatives panel. The event, titled “Democracy’s Global Test: Reflections on the Year of Elections,” aimed to explore threats to democracy, important elections and their international impact in the “biggest election year in history.”
George Santos’ former seat filled by moderate Democrat
After the announcement of 23 fraud charges against Santos, a bipartisan vote (311-114) expelled Santos from the House of Representatives, according to CNN. This removal makes Rep. Santos only the sixth person expelled from the House of Representatives. This left a critical seat open for the narrow Republican majority. The two candidates for the seat were Republican Mazi Pilip and former New York Democratic Congressman Tom Suozzi.